Sepsis Stewardship: The Puzzle of Antibiotic Therapy in the Context of Individualization of Decision Making

被引:3
作者
Ramasco, Fernando [1 ]
Mendez, Rosa [1 ]
de la Rica, Alejandro Suarez [1 ]
de Castro, Rafael Gonzalez [2 ]
Maseda, Emilio [3 ]
机构
[1] Hosp Univ La Princesa, Dept Anaesthesiol & Surg Intens Care, Diego Leon 62, Madrid 28006, Spain
[2] Univ Hosp Leon, Dept Rheumatol, Leon 24071, Spain
[3] Hosp Univ Fdn Alcorcon, Dept Traumatol & Orthopaed Surg, Madrid, Spain
来源
JOURNAL OF PERSONALIZED MEDICINE | 2024年 / 14卷 / 01期
关键词
Antimicrobial Stewardship; sparing carbapenems; new antibiotics; antimicrobial resistance; individualization; antibiotic treatment; sepsis; septic shock; Gram negatives; VENTILATOR-ASSOCIATED PNEUMONIA; INFECTIOUS-DISEASES SOCIETY; INTENSIVE-CARE-UNIT; BETA-LACTAM ANTIBIOTICS; CRITICALLY-ILL PATIENTS; ANTIMICROBIAL THERAPY; SEPTIC SHOCK; CLINICAL MICROBIOLOGY; AMERICAN-COLLEGE; EUROPEAN-SOCIETY;
D O I
10.3390/jpm14010106
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The main recent change observed in the field of critical patient infection has been universal awareness of the need to make better use of antimicrobials, especially for the most serious cases, beyond the application of simple and effective formulas or rigid protocols. The increase in resistant microorganisms, the quantitative increase in major surgeries and interventional procedures in the highest risk patients, and the appearance of a significant number of new antibiotics in recent years (some very specifically directed against certain mechanisms of resistance and others with a broader spectrum of applications) have led us to shift our questions from "what to deal with" to "how to treat". There has been controversy about how best to approach antibiotic treatment of complex cases of sepsis. The individualized and adjusted dosage, the moment of its administration, the objective, and the selection of the regimen are pointed out as factors of special relevance in a critically ill patient where the frequency of resistant microorganisms, especially among the Enterobacterales group, and the emergence of multiple and diverse antibiotic treatment alternatives have made the appropriate choice of antibiotic treatment more complex, requiring a constant updating of knowledge and the creation of multidisciplinary teams to confront new infections that are difficult to treat. In this article, we have reviewed the phenomenon of the emergence of resistance to antibacterials and we have tried to share some of the ideas, such as stewardship, sparing carbapenems, and organizational, microbiological, pharmacological, and knowledge tools, that we have considered most useful and effective for individualized decision making that takes into account the current context of multidrug resistance. The greatest challenge, therefore, of decision making in this context lies in determining an effective, optimal, and balanced empirical antibiotic treatment.
引用
收藏
页数:37
相关论文
共 167 条
  • [11] Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria
    Bassetti, Matteo
    Righi, Elda
    Vena, Antonio
    Graziano, Elena
    Russo, Alessandro
    Peghin, Maddalena
    [J]. CURRENT OPINION IN CRITICAL CARE, 2018, 24 (05) : 385 - 393
  • [12] Optimizing antibiotic therapies to reduce the risk of bacterial resistance
    Bassetti, Stefano
    Tschudin-Sutter, Sarah
    Egli, Adrian
    Osthoff, Michael
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 99 : 7 - 12
  • [13] Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project
    Blot, Stijn
    Antonelli, Massimo
    Arvaniti, Kostoula
    Blot, Koen
    Creagh-Brown, Ben
    de Lange, Dylan
    De Waele, Jan
    Deschepper, Mieke
    Dikmen, Yalim
    Dimopoulos, George
    Eckmann, Christian
    Francois, Guy
    Girardis, Massimo
    Koulenti, Despoina
    Labeau, Sonia
    Lipman, Jeffrey
    Lipovestky, Fernando
    Maseda, Emilio
    Montravers, Philippe
    Mikstacki, Adam
    Paiva, Jose-Artur
    Pereyra, Cecilia
    Rello, Jordi
    Timsit, Jean-Francois
    Vogelaers, Dirk
    Lamrous, Amin
    Rezende-Neto, Joao
    Cardenas, Yenny
    Vymazal, Tomas
    Fjeldsoee-Nielsen, Hans
    Kott, Matthias
    Kostoula, Arvaniti
    Javeri, Yash
    Einav, Sharon
    Umezawa Makikado, Luis Daniel
    Tomescu, Dana
    Gritsan, Alexey
    Jovanovic, Bojan
    Venkatesan, Kumaresh
    Mirkovic, Tomislav
    Creagh-Brown, Benedict
    Emmerich, Monica
    Canale, Mariana
    Silvina Dietz, Lorena
    Ilutovich, Santiago
    Sanchez Minope, John Thomas
    Baldomera Silva, Ramona
    Alexis Montenegro, Martin
    Martin, Patricio
    Saul, Pablo
    [J]. INTENSIVE CARE MEDICINE, 2019, 45 (12) : 1703 - 1717
  • [14] Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
    Bouadma, Lila
    Luyt, Charles-Edouard
    Tubach, Florence
    Cracco, Christophe
    Alvarez, Antonio
    Schwebel, Carole
    Schortgen, Frederique
    Lasocki, Sigismond
    Veber, Benoit
    Dehoux, Monique
    Bernard, Maguy
    Pasquet, Blandine
    Regnier, Bernard
    Brun-Buisson, Christian
    Chastre, Jean
    Wolff, Michel
    [J]. LANCET, 2010, 375 (9713) : 463 - 474
  • [15] Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial
    Bougle, Adrien
    Tuffet, Sophie
    Federici, Laura
    Leone, Marc
    Monsel, Antoine
    Dessalle, Thomas
    Amour, Julien
    Dahyot-Fizelier, Claire
    Barbier, Francois
    Luyt, Charles-Edouard
    Langeron, Olivier
    Cholley, Bernard
    Pottecher, Julien
    Hissem, Tarik
    Lefrant, Jean-Yves
    Veber, Benoit
    Legrand, Matthieu
    Demoule, Alexandre
    Kalfon, Pierre
    Constantin, Jean-Michel
    Rousseau, Alexandra
    Simon, Tabassome
    Foucrier, Arnaud
    [J]. INTENSIVE CARE MEDICINE, 2022, 48 (07) : 841 - 849
  • [16] Cotrimoxazole - optimal dosing in the critically ill
    Brown, Glen R.
    [J]. ANNALS OF INTENSIVE CARE, 2014, 4
  • [17] Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK
    Brown, Nicholas M.
    Goodman, Anna L.
    Horner, Carolyne
    Jenkins, Abi
    Brown, Erwin M.
    [J]. JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 (01):
  • [18] Faster infection diagnostics for intensive care unit (ICU) patients
    Burillo, Almudena
    Bouza, Emilio
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2022, 22 (03) : 347 - 360
  • [19] Risk stratification for multidrug-resistant Gram-negative infections in ICU patients
    Burillo, Almudena
    Munoz, Patricia
    Bouza, Emilio
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2019, 32 (06) : 626 - 637
  • [20] Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Validation of Scores and Proposal for Management
    Cano, Angela
    Gutierrez-Gutierrez, Belen
    Machuca, Isabel
    Gracia-Ahufinger, Irene
    Perez-Nadales, Elena
    Causse, Manuel
    Jose Caston, Juan
    Guzman-Puche, Julia
    Torre-Gimenez, Julian
    Kindelan, Lara
    Martinez-Martinez, Luis
    Rodriguez-Bano, Jesus
    Torre-Cisneros, Julian
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (08) : 1204 - 1210